Drug Therapy

Jaime F. Avecillas, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Joseph A. Golish, MD
Department of Pulmonary and Critical Care Medicine and Department of Neurology, The Cleveland Clinic Foundation

Carmen Giannini, RN, BSN
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

José C. Yataco, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Joseph Golish, MD, Department of Pulmonary and Critical Care Medicine, A90, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jaime F. Avecillas, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Joseph A. Golish, MD
Department of Pulmonary and Critical Care Medicine and Department of Neurology, The Cleveland Clinic Foundation

Carmen Giannini, RN, BSN
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

José C. Yataco, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Joseph Golish, MD, Department of Pulmonary and Critical Care Medicine, A90, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jaime F. Avecillas, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Joseph A. Golish, MD
Department of Pulmonary and Critical Care Medicine and Department of Neurology, The Cleveland Clinic Foundation

Carmen Giannini, RN, BSN
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

José C. Yataco, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Joseph Golish, MD, Department of Pulmonary and Critical Care Medicine, A90, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Nicole C. Dombrowski, DO
Internal Medicine Center, Akron City Hospital, Summa Health System, Akron, OH

Wilma F. Bergfeld, MD
Head, Clinical Research, Department of Dermatology, The Cleveland Clinic Foundation

Address: Nicole C. Dombrowski, DO, Internal Medicine Center, Akron City Hospital, 55 Arch Street, Suite 1B, Akron, OH 44304

Nicole C. Dombrowski, DO
Internal Medicine Center, Akron City Hospital, Summa Health System, Akron, OH

Wilma F. Bergfeld, MD
Head, Clinical Research, Department of Dermatology, The Cleveland Clinic Foundation

Address: Nicole C. Dombrowski, DO, Internal Medicine Center, Akron City Hospital, 55 Arch Street, Suite 1B, Akron, OH 44304

Nicole C. Dombrowski, DO
Internal Medicine Center, Akron City Hospital, Summa Health System, Akron, OH

Wilma F. Bergfeld, MD
Head, Clinical Research, Department of Dermatology, The Cleveland Clinic Foundation

Address: Nicole C. Dombrowski, DO, Internal Medicine Center, Akron City Hospital, 55 Arch Street, Suite 1B, Akron, OH 44304

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail [email protected]

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail [email protected]

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail [email protected]

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Matt Rosenberg, MD
Mid-Michigan Health Centers, Jackson, MI

C. Lowell Parsons, MD
Division of Urology, University of California San Diego Medical Center, San Diego, CA

Shari Page, FNP
Mid-Michigan Health Centers, Jackson, MI

Address: Matt Rosenberg, MD, Mid-Michigan Health Centers, 214 North West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he has received grant or research support from the Ortho-McNeil corporation and has served as a consultant for and on the speaker’s bureaus of the GlaxoSmithKline, Lilly, Novartis, Ortho-McNeil Pharmaceutical, Pfizer, and Reliant corporations.

Dr. Parsons has indicated that he has served as a lecturer and consultant for the Ortho-McNeil corporation.

Ms. Page has indicated that she has served as a lecturer and consultant for the Ortho-McNeil corporation.

Matt Rosenberg, MD
Mid-Michigan Health Centers, Jackson, MI

C. Lowell Parsons, MD
Division of Urology, University of California San Diego Medical Center, San Diego, CA

Shari Page, FNP
Mid-Michigan Health Centers, Jackson, MI

Address: Matt Rosenberg, MD, Mid-Michigan Health Centers, 214 North West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he has received grant or research support from the Ortho-McNeil corporation and has served as a consultant for and on the speaker’s bureaus of the GlaxoSmithKline, Lilly, Novartis, Ortho-McNeil Pharmaceutical, Pfizer, and Reliant corporations.

Dr. Parsons has indicated that he has served as a lecturer and consultant for the Ortho-McNeil corporation.

Ms. Page has indicated that she has served as a lecturer and consultant for the Ortho-McNeil corporation.

Matt Rosenberg, MD
Mid-Michigan Health Centers, Jackson, MI

C. Lowell Parsons, MD
Division of Urology, University of California San Diego Medical Center, San Diego, CA

Shari Page, FNP
Mid-Michigan Health Centers, Jackson, MI

Address: Matt Rosenberg, MD, Mid-Michigan Health Centers, 214 North West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he has received grant or research support from the Ortho-McNeil corporation and has served as a consultant for and on the speaker’s bureaus of the GlaxoSmithKline, Lilly, Novartis, Ortho-McNeil Pharmaceutical, Pfizer, and Reliant corporations.

Dr. Parsons has indicated that he has served as a lecturer and consultant for the Ortho-McNeil corporation.

Ms. Page has indicated that she has served as a lecturer and consultant for the Ortho-McNeil corporation.